Australian Statistics on Medicines 2011
Table 1 - Alimentary Tract And Metabolism
- ALIMENTARY TRACT AND METABOLISM
- A01 - STOMATOLOGICAL PREPARATIONS
- A02 - DRUGS FOR ACID RELATED DISORDERS
- A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
- A04 - ANTIEMETICS AND ANTINAUSEANTS
- A05 - BILE AND LIVER THERAPY
- A06 - LAXATIVES
- A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
- A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
- A09 - DIGESTIVES INCL ENZYMES
- A10 - ANTIDIABETIC THERAPY
- A11 - VITAMINS
- A12 - MINERAL SUPPLEMENTS
- A14 - ANABOLIC AGENTS FOR SYSTEMIC USE
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A01AB04 |
AMPHOTERICIN |
||||||
P |
2931G |
Lozenge 10mg |
40.00 |
MG |
148,438 |
1,839,338 |
|
P |
3306B |
Lozenge 10mg |
40.00 |
MG |
3,767 |
45,298 |
|
A01AB03 |
CHLORHEXIDINE |
||||||
A |
21081 |
Mouth wash 2mg per mL (0.2%) 300mL |
30.00 |
MG |
835 |
- |
|
P |
4204G |
Mouth wash 2mg per mL (0.2%) 300mL |
30.00 |
MG |
1,590 |
25,464 |
|
A01AB09 |
MICONAZOLE |
||||||
A |
13832 |
Oral gel 20mg per mL (2%) 20g |
0.20 |
GM |
2,685 |
- |
|
A |
14054 |
Oral gel 40mg per mL (2%) 40g |
0.20 |
GM |
2,114 |
- |
|
A01AB11 |
NYSTATIN |
||||||
P |
3033P |
Oral suspension 100,000 units per mL 24mL |
1500.00 |
TE |
148,521 |
1,636,666 |
|
P |
3343Y |
Oral suspension 100,000 units per mL 24mL |
1500.00 |
TE |
956 |
10,406 |
|
CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT |
|||||||
A01AC01 |
TRIAMCINOLONE ACETONIDE with PECTIN |
||||||
A |
11075 |
Paste 1% 5gm |
- |
- |
11,933 |
- |
|
OTHER AGENTS FOR LOCAL ORAL TREATMENT |
|||||||
A01AD02 |
BENZYDAMINE HYDROCHLORIDE |
||||||
P |
1121B |
Mouth and throat rinse 22.5mg per 15mL 500mL |
- |
- |
3,933 |
83,728 |
|
P |
5032W |
Mouth and throat rinse 22.5mg per 15mL 500mL |
- |
- |
190 |
4,221 |
|
P |
5385K |
Mouth and throat rinse 22.5mg per 15mL 500mL |
- |
- |
260 |
6,134 |
|
A01AD02 |
BENZYDAMINE with CHLORHEXIDINE |
||||||
A |
14359 |
Solution 200mL |
- |
- |
217 |
- |
|
A01AD11 |
CHOLINE SALICYLATE with CETALKONIUM CHLORIDE |
||||||
A |
12855 |
Gel 10g 1 |
- |
- |
1,943 |
- |
|
A01AD11 |
SALIVA SUBSTITUTE |
||||||
P |
4568K |
Solution 25mL |
- |
- |
385 |
4,253 |
|
P |
4569L |
Solution 100mL |
- |
- |
683 |
9,695 |
|
A01AD11 |
VARIOUS |
||||||
P |
5334R |
Spray 10mg per mL 100mL |
- |
- |
173 |
2,332 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A02AB01 |
ALUMINIUM HYDROXIDE |
||||||
A |
10038 |
Tablet 600mg 100 |
- |
- |
2,956 |
- |
|
CALCIUM COMPOUNDS |
|||||||
A02AC10 |
CALCIUM CARBONATE with GLYCINE |
||||||
P |
4055K |
Tablet 420mg-180mg |
- |
- |
506 |
11,828 |
|
COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS |
|||||||
A02AD |
ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE |
||||||
P |
2157M |
Oral suspension 200mg-200mg per 5mL 500mL |
- |
- |
89,527 |
1,375,886 |
|
P |
4118R |
Oral suspension 400mg-400mg-30mg per 5mL |
- |
- |
1,871 |
41,738 |
|
A02AD |
ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE |
||||||
A |
20644 |
Chewable tablet 200mg-200mg-20mg 100 |
- |
- |
126 |
- |
|
P |
4453J |
Tablet 400mg-400mg-40mg 200 |
- |
- |
1,243 |
55,850 |
|
A02AD |
ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE |
||||||
P |
2159P |
Oral suspension 250mg-120mg-120mg per 5mL |
- |
- |
16,883 |
292,640 |
|
DRUGS FOR PEPTIC ULCER AND GORD |
|||||||
H2-RECEPTOR ANTAGONISTS |
|||||||
A02BA01 |
CIMETIDINE |
||||||
P |
1157X |
Tablet 200mg |
0.80 |
GM |
938 |
12,710 |
|
P |
1158Y |
Tablet 400mg |
0.80 |
GM |
4,020 |
73,667 |
|
P |
1159B |
Tablet 800mg |
0.80 |
GM |
988 |
18,574 |
|
A02BA03 |
FAMOTIDINE |
||||||
P |
2487X |
Tablet 20mg |
40.00 |
MG |
39,288 |
662,829 |
|
P |
2488Y |
Tablet 40mg |
40.00 |
MG |
49,746 |
890,048 |
|
A02BA04 |
NIZATIDINE |
||||||
P |
1504E |
Capsules 300mg 30 |
0.30 |
GM |
71,717 |
1,353,059 |
|
P |
1505F |
Capsules 150mg 30 |
0.30 |
GM |
85,373 |
1,574,240 |
|
A02BA02 |
RANITIDINE HYDROCHLORIDE |
||||||
P |
1937Y |
Effervescent tablet 150mg (base) |
0.30 |
GM |
41,009 |
708,025 |
|
P |
1977C |
Tablet 300mg (base) |
0.30 |
GM |
274,134 |
4,850,962 |
|
P |
1978D |
Tablet 150mg (base) |
0.30 |
GM |
538,072 |
9,265,705 |
|
P |
8162N |
Syrup 150mg (base) per 10mL 300mL |
0.30 |
GM |
25,325 |
510,769 |
|
P |
8903N |
Effervescent tablet 150mg (base) |
0.30 |
GM |
1,047 |
22,799 |
|
P |
8905Q |
Syrup 150mg (base) per 10mL 300mL |
0.30 |
GM |
585 |
15,282 |
|
PROSTAGLANDINS |
|||||||
A02BB01 |
MISOPROSTOL |
||||||
P |
1648R |
Tablet 200ug |
0.80 |
MG |
2,046 |
106,026 |
|
PROTON PUMP INHIBITORS |
|||||||
A02BC05 |
ESOMEPRAZOLE |
||||||
A |
20665 |
Sachet granules 10mg 30 |
30.00 |
MG |
7,264 |
- |
|
P |
3401B |
Tablet 40mg (enteric coated) 30 |
30.00 |
MG |
45,887 |
2,608,186 |
|
P |
8600P |
Tablet 20mg (enteric coated) 30 |
30.00 |
MG |
4,004,220 |
125,045,481 |
|
P |
8601Q |
Tablet 40mg (enteric coated) 30 |
30.00 |
MG |
2,791,158 |
132,488,955 |
|
P |
8886Q |
Tablet 20mg (enteric coated) 30 |
30.00 |
MG |
130,397 |
4,051,301 |
|
A02BC03 |
LANSOPRAZOLE |
||||||
P |
2240X |
Capsule 30mg 28 |
30.00 |
MG |
3,639 |
107,752 |
|
P |
2241Y |
Capsule 30mg 28 |
30.00 |
MG |
121,002 |
3,516,631 |
|
P |
8198L |
Capsule 15mg 28 |
30.00 |
MG |
3,459 |
69,902 |
|
P |
9331D |
Capsule 15mg 28 |
30.00 |
MG |
18,012 |
338,344 |
|
P |
9477T |
Tablet 30mg (orally disintegrating) 28 |
30.00 |
MG |
12,329 |
348,423 |
|
P |
9478W |
Tablet 30mg (orally disintegrating) 28 |
30.00 |
MG |
433,333 |
13,820,017 |
|
A02BC01 |
OMEPRAZOLE |
||||||
P |
1326T |
Capsule 20mg |
20.00 |
MG |
6,794 |
189,891 |
|
P |
1327W |
Capsule 20mg |
20.00 |
MG |
181,744 |
6,052,848 |
|
P |
8331L |
Tablet 20mg (as magnesium salt) 30 |
20.00 |
MG |
45,590 |
1,161,582 |
|
P |
8332M |
Tablet 10mg (as magnesium salt) 30 |
20.00 |
MG |
70,823 |
1,604,361 |
|
P |
8333N |
Tablet 20mg (as magnesium salt) 30 |
20.00 |
MG |
989,364 |
28,689,105 |
|
P |
9109K |
Tablet 20mg (as magnesium salt) 30 |
20.00 |
MG |
34,684 |
974,893 |
|
P |
9110L |
Tablet 20mg (as magnesium salt) 30 |
20.00 |
MG |
1,681,829 |
58,230,855 |
|
A02BC02 |
PANTOPRAZOLE |
||||||
A |
20488 |
Tablet (enteric coated) equivalent to 20mg 7 |
40.00 |
MG |
381 |
- |
|
A |
20489 |
Tablet (enteric coated) equivalent to 20mg 14 |
40.00 |
MG |
1,370 |
- |
|
A |
21229 |
Tablet (enteric coated) equivalent to 20mg 14 |
40.00 |
MG |
141 |
- |
|
P |
8007K |
Tablet (enteric coated) equivalent to 40mg |
40.00 |
MG |
394,965 |
11,960,309 |
|
P |
8008L |
Tablet (enteric coated) equivalent to 40mg |
40.00 |
MG |
3,596,247 |
119,982,837 |
|
P |
8399C |
Tablet (enteric coated) equivalent to 20mg |
40.00 |
MG |
513,893 |
9,518,568 |
|
P |
9423Y |
Sachet containing granules 40mg 30 |
40.00 |
MG |
4,277 |
130,322 |
|
P |
9424B |
Sachet containing granules 40mg 30 |
40.00 |
MG |
33,536 |
1,074,357 |
|
A02BC04 |
RABEPRAZOLE |
||||||
A |
17042 |
Tablet 10mg 7 |
20.00 |
MG |
131 |
- |
|
A |
21419 |
Tablet 10mg 14 |
20.00 |
MG |
238 |
- |
|
P |
8507R |
Tablet 10mg 30 |
20.00 |
MG |
79,844 |
2,873,533 |
|
P |
8508T |
Tablet 20mg 30 |
20.00 |
MG |
2,307,116 |
89,389,670 |
|
P |
8509W |
Tablet 20mg 30 |
20.00 |
MG |
239,671 |
8,507,492 |
|
COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI |
|||||||
A02BD06 |
ESOMEPRAZOLE AMOXICILAN and CLARITHROMYCIN |
||||||
P |
8738X |
Pack 14 tabs(ent coated)equiv 20mg esomeprazole |
- |
- |
86,235 |
6,713,133 |
|
A02BD05 |
OMEPRAZOLE and CLARITHROMYCIN and AMOXYCILLIN |
||||||
P |
8272J |
Pack 14 caps 20mg,14 tabs 500mg,28 caps 500mg |
- |
- |
7,108 |
464,015 |
|
OTHER DRUGS FOR PEPTIC ULCER AND GORD |
|||||||
A02BX13 |
SODIUM ALGINATE with CALCIUM CARBONATE and SODIUM BICARBONATE |
||||||
P |
2014B |
Oral liquid 1gm-320mg in 20mL 500mL |
- |
- |
111,380 |
1,631,322 |
|
A02BX02 |
SUCRALFATE |
||||||
P |
2055E |
Tablet 1g |
4.00 |
GM |
16,616 |
389,048 |
|
ANTIFLATULENTS |
|||||||
ANTIFLATULENTS |
|||||||
A02DA |
PEPPERMINT OIL |
||||||
A |
13210 |
Capsule 0.2mL 63 |
- |
- |
778 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A03AA04 |
MEBEVERINE HYDROCHLORIDE |
||||||
A |
12730 |
Tablet 135mg 30 |
0.30 |
GM |
16,166 |
- |
|
A |
14130 |
Tablet 135mg 30 |
0.30 |
GM |
11,045 |
- |
|
P |
4328T |
Tablet 135mg |
0.30 |
GM |
60,233 |
1,809,221 |
|
SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND |
|||||||
A03AB05 |
PROPANTHELINE |
||||||
P |
1953T |
Tablet 15mg |
60.00 |
MG |
15,859 |
403,508 |
|
OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
|||||||
A03AX13 |
SIMETHICONE |
||||||
A |
13445 |
Capsule 100mg 30 |
- |
- |
134 |
- |
|
BELLADONNA AND DERIVATIVES PLAIN |
|||||||
BELLADONNA ALKALOIDS TERTIARY AMINES |
|||||||
A03BA01 |
ATROPINE |
||||||
P |
1089H |
Injection 600ug in 1mL 10 |
1.50 |
MG |
2,940 |
38,036 |
|
P |
3453R |
Injection 600ug in 1mL 10 |
1.50 |
MG |
6,880 |
140,049 |
|
BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND |
|||||||
A03BB01 |
BUTYLSCOPOLAMINE |
||||||
A |
12939 |
Tablet 10mg 100 |
60.00 |
MG |
9,964 |
- |
|
A |
15287 |
Tablet 10mg |
60.00 |
MG |
7,849 |
- |
|
P |
3473T |
Injection 20mg in 1mL 5 |
60.00 |
MG |
6,797 |
164,471 |
|
P |
4279F |
Injection 20mg in 1mL |
60.00 |
MG |
4,133 |
176,530 |
|
P |
5317W |
Injection 20mg in 1mL |
60.00 |
MG |
1,916 |
256,767 |
|
P |
5318X |
Injection 20mg in 1mL |
60.00 |
MG |
812 |
103,405 |
|
A03BB |
HYOSCINE HYDROBROMIDE |
||||||
A |
10972 |
Ampoule 400ug 5 |
- |
- |
9,418 |
- |
|
PROPULSIVES |
|||||||
PROPULSIVES |
|||||||
A03FA03 |
DOMPERIDONE |
||||||
A |
11309 |
Tablet 10mg 100 |
30.00 |
MG |
17,576 |
- |
|
P |
1347X |
Tablet 10mg |
30.00 |
MG |
348,065 |
4,423,328 |
|
A03FA01 |
METOCLOPRAMIDE HYDROCHLORIDE |
||||||
A |
11138 |
Tablet 10mg 100 |
30.00 |
MG |
2,639 |
- |
|
P |
1206L |
Injection 10mg in 2mL |
30.00 |
MG |
45,196 |
657,177 |
|
P |
1207M |
Tablet 10mg |
30.00 |
MG |
822,073 |
7,101,214 |
|
P |
3476Y |
Injection 10mg in 2mL |
30.00 |
MG |
28,267 |
366,744 |
|
P |
5151D |
Tablet 10mg |
30.00 |
MG |
557 |
4,509 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A04AA04 |
DOLASETRON MESYLATE |
||||||
P |
8191D |
Tablet 200mg |
0.20 |
GM |
2,350 |
127,372 |
|
P |
8192E |
I.V. injection 100mg in 5mL |
0.10 |
GM |
545 |
18,030 |
|
A04AA02 |
GRANISETRON |
||||||
P |
5898K |
Tablet 2mg (base) 2 |
2.00 |
MG |
8,811 |
498,084 |
|
P |
5899L |
Concentrated injection 3mg (base) in 3mL |
3.00 |
MG |
8,950 |
236,723 |
|
P |
8728J |
Tablet 2mg (base) 2 |
2.00 |
MG |
34,227 |
2,207,167 |
|
P |
8729K |
Concentrated injection 3mg (base) in 3mL |
3.00 |
MG |
38,631 |
1,560,739 |
|
P |
8873B |
Tablet 2mg (base) 5 |
2.00 |
MG |
1,063 |
212,100 |
|
A04AA01 |
ONDANSETRON |
||||||
P |
1594X |
Tablet 4mg |
16.00 |
MG |
7,083 |
545,130 |
|
P |
1595Y |
Tablet 8mg |
16.00 |
MG |
8,105 |
970,905 |
|
P |
5471Y |
Tablet (orally disintegrating) 8mg 4 |
16.00 |
MG |
115 |
5,463 |
|
P |
5967C |
Tablet 4mg |
16.00 |
MG |
763 |
20,718 |
|
P |
5968D |
Tablet 8mg |
16.00 |
MG |
18,040 |
670,561 |
|
P |
5969E |
Wafer 4mg 4 |
16.00 |
MG |
134 |
4,559 |
|
P |
5970F |
Wafer 8mg 4 |
16.00 |
MG |
1,222 |
62,348 |
|
P |
5972H |
I.V. injection 8mg in 4mL |
16.00 |
MG |
13,443 |
212,150 |
|
P |
8224W |
Tablet 4mg |
16.00 |
MG |
15,987 |
607,366 |
|
P |
8225X |
Tablet 8mg |
16.00 |
MG |
51,457 |
2,722,953 |
|
P |
8226Y |
I.V. injection 4mg in 2mL |
16.00 |
MG |
2,420 |
47,031 |
|
P |
8227B |
I.V. injection 8mg in 4mL |
16.00 |
MG |
18,672 |
595,894 |
|
P |
8233H |
Syrup 4mg per 5mL 50mL |
16.00 |
MG |
126 |
15,135 |
|
P |
8410P |
Wafer 4mg 4 |
16.00 |
MG |
35,853 |
1,287,731 |
|
P |
8411Q |
Wafer 8mg 4 |
16.00 |
MG |
25,304 |
1,499,780 |
|
P |
8412R |
Wafer 4mg 10 |
16.00 |
MG |
13,132 |
1,081,046 |
|
P |
8413T |
Wafer 8mg 10 |
16.00 |
MG |
12,370 |
1,565,176 |
|
P |
9441X |
Syrup 4mg per 5mL 50mL 1 |
16.00 |
MG |
263 |
26,686 |
|
A04AA05 |
PALONOSETRON |
||||||
P |
5295Q |
Injection 250ug (as hydrochloride) in 5mL 1 |
0.25 |
MG |
40,834 |
1,917,786 |
|
P |
5853C |
Injection 250ug (as hydrochloride) in 5mL |
0.25 |
MG |
3,493 |
120,157 |
|
A04AA03 |
TROPISETRON |
||||||
P |
2745L |
Capsule 5mg (base) |
5.00 |
MG |
16,955 |
999,640 |
|
P |
2746M |
I.V. injection 5mg/5mL |
5.00 |
MG |
9,949 |
344,405 |
|
P |
5986C |
Capsule 5mg (base) |
5.00 |
MG |
5,200 |
183,453 |
|
P |
5987D |
I.V. injection 5mg/5mL |
5.00 |
MG |
4,342 |
81,530 |
|
VARIOUS ANTIEMETICS |
|||||||
A04AD12 |
APREPITANT |
||||||
P |
5888X |
Pack 1 cap 125mg and 2 cap 80mg |
95.00 |
MG |
12,562 |
1,407,070 |
|
P |
8808N |
Pack 1 cap 125mg and 2 cap 80mg |
95.00 |
MG |
35,174 |
4,824,412 |
|
A04AD01 |
SCOPOLAMINE |
||||||
A |
20612 |
Tablet 20mg 10 |
60.00 |
MG |
968 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A05AA02 |
URSODEOXYCHOLIC ACID |
||||||
P |
8448P |
Capsule 250mg 200 |
0.75 |
GM |
28,220 |
9,996,969 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A06AA02 |
DOCUSATE SODIUM |
||||||
A |
16099 |
Tablet 120mg 100 |
0.15 |
GM |
10,849 |
- |
|
P |
4200C |
Tablet 50mg |
0.15 |
GM |
9,436 |
135,168 |
|
A06AA01 |
LIQUID PARAFFIN |
||||||
A |
10108 |
Oral suspension vanilla 500mL |
15.00 |
GM |
519 |
- |
|
A |
10120 |
Oral suspension strawberry 500mL |
15.00 |
GM |
156 |
- |
|
A06AA |
POLOXALKOL |
||||||
A |
10469 |
Drop 10% 30mL 1 |
- |
- |
1,427 |
- |
|
CONTACT LAXATIVES |
|||||||
A06AB02 |
BISACODYL |
||||||
A |
10635 |
Tablet 5mg 200 |
10.00 |
MG |
382 |
- |
|
P |
1258F |
Suppositories 10mg 12 |
10.00 |
MG |
3,466 |
62,058 |
|
P |
1259G |
Tablet 5mg |
10.00 |
MG |
26,841 |
376,477 |
|
P |
1260H |
Suppositories 10mg 10 |
10.00 |
MG |
30,370 |
616,263 |
|
P |
3250C |
Suppositories 10mg 10 |
10.00 |
MG |
595 |
23,485 |
|
P |
5303D |
Suppositories 10mg 10 |
10.00 |
MG |
179 |
3,932 |
|
A06AB56 |
DOCUSATE SODIUM with SENNA |
||||||
A |
12753 |
Tablet 30 |
- |
- |
5,586 |
- |
|
P |
4028B |
Tablet 50mg-8mg 100 |
- |
- |
15,686 |
226,834 |
|
P |
4198Y |
Tablet 50mg-8mg 90 |
- |
- |
233,283 |
3,899,346 |
|
A06AB06 |
SENNA STANDARDISED |
||||||
P |
4455L |
Tablet 7.5mg |
- |
- |
9,006 |
125,332 |
|
BULK PRODUCERS |
|||||||
A06AC51 |
ISPAGHULA COMBINATIONS |
||||||
P |
4416K |
Oral Powder 440g |
- |
- |
592 |
12,652 |
|
A06AC01 |
PSYLLIUM HYDROPHILIC MUCILLOID |
||||||
A |
11156 |
Powder 500g 1 |
7.00 |
GM |
962 |
- |
|
A |
11273 |
Powder 500g 1 |
7.00 |
GM |
390 |
- |
|
P |
4285M |
Sachets 3.5g 30 |
7.00 |
GM |
2,213 |
44,489 |
|
P |
4419N |
Oral powder(orange-flavour sugar free)315g |
7.00 |
GM |
20,359 |
456,491 |
|
P |
4422R |
Oral powder (non-flavoured) 375g |
7.00 |
GM |
11,705 |
261,632 |
|
A06AC53 |
STERCULIA with FRANGULA BARK |
||||||
P |
1104D |
Granules 620mg-80mg per g (62%-8%) 500g |
- |
- |
70,371 |
1,768,572 |
|
P |
3275J |
Granules 620mg-80mg per g (62%-8%) 500g |
- |
- |
807 |
25,712 |
|
P |
4558X |
Granules 620mg-80mg per g (62%-8%) 500g |
- |
- |
5,428 |
136,948 |
|
A06AC53 |
STERCULIA, COMBINATIONS |
||||||
P |
5322D |
Granules 620mg-80mg per g (62%-8%) 500g |
- |
- |
302 |
7,952 |
|
OSMOTICALLY ACTING LAXATIVES |
|||||||
A06AD11 |
LACTULOSE |
||||||
P |
3064G |
Mixture 3.34g per 5mL 500mL |
6.70 |
GM |
345,133 |
4,789,487 |
|
P |
5387M |
Mixture 3.34g per 5mL 500mL 1 |
6.70 |
GM |
7,360 |
167,243 |
|
P |
5388N |
Mixture 3.34g per 5mL 500mL 1 |
6.70 |
GM |
1,138 |
32,003 |
|
A06AD11 |
LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE |
||||||
A |
10693 |
Syrup 200mL 1 |
6.70 |
GM |
478 |
- |
|
A06AD15 |
MACROGOL |
||||||
P |
3278M |
Sachets powder 13.125g with electrolytes 2 |
10.00 |
GM |
1,162 |
28,980 |
|
P |
3416T |
Powder for oral solution 510g |
10.00 |
GM |
34,938 |
719,586 |
|
P |
5389P |
Sachets powder 13.125g with electrolytes 30 |
10.00 |
GM |
6,795 |
238,181 |
|
P |
5390Q |
Sachets powder 13.125g with electrolytes 30 |
10.00 |
GM |
1,648 |
59,056 |
|
P |
5426N |
Powder for oral solution 510g |
10.00 |
GM |
242 |
8,085 |
|
P |
8612G |
Sachets powder 13.125g with electrolytes 30 |
10.00 |
GM |
893,738 |
18,628,515 |
|
A06AD |
SORBITOL |
||||||
A |
14787 |
Liquid 70% 500mL |
- |
- |
17,224 |
- |
|
ENEMAS |
|||||||
A06AG02 |
BISACODYL |
||||||
P |
1263L |
Enemas 10mg in 5mL 25 |
- |
- |
9,608 |
415,704 |
|
P |
3263R |
Enemas 10mg in 5mL 25 |
- |
- |
3,447 |
191,213 |
|
P |
5302C |
Enemas 10mg in 5mL 25 |
10.00 |
MG |
349 |
16,123 |
|
A06AG20 |
COMBINATION (SORBITOL/SODIUM CITRATE/SODIUM LAURYL SULFOACETATE) |
||||||
P |
2091C |
Enemas 3.125g-450mg-45mg in 5mL 12 |
- |
- |
46,943 |
1,514,964 |
|
P |
3274H |
Enemas 3.125g-450mg-45mg in 5mL 12 |
- |
- |
4,309 |
195,042 |
|
P |
4462W |
Enemas 3.125g-450mg-45mg in 5mL 4 |
- |
- |
2,483 |
32,683 |
|
P |
5331N |
Enemas 3.125g-450mg-45mg in 5mL 12 |
- |
- |
1,183 |
42,469 |
|
P |
5332P |
Enemas 3.125g-450mg-45mg in 5mL 12 |
- |
- |
261 |
10,540 |
|
A06AG01 |
SODIUM PHOSPHATE |
||||||
A |
15629 |
Laxative Mixt 3.3G/5mL |
- |
- |
677 |
- |
|
PERIPHERAL OPIOID RECEPTOR ANTAGONISTS |
|||||||
A06AH01 |
METHYLNALTREXONE BROMIDE |
||||||
P |
5423K |
Solution for injection 12mg in 0.6mL 7 |
6.00 |
MG |
216 |
30,898 |
|
P |
5424L |
Solution for injection 12mg in 0.6mL 7 |
6.00 |
MG |
122 |
44,611 |
|
OTHER LAXATIVES |
|||||||
A06AX01 |
GLYCEROL |
||||||
P |
2555L |
Suppositories 700mg (for infants) 12 |
- |
- |
394 |
6,575 |
|
P |
2556M |
Suppositories 1.4g (for children) 12 |
- |
- |
769 |
14,174 |
|
P |
2557N |
Suppositories 2.8g (for adults) 12 |
- |
- |
9,213 |
172,117 |
|
P |
3267Y |
Suppositories 2.8g (for adults) 12 |
- |
- |
238 |
7,238 |
|
P |
4246L |
Suppositories 2.8g (for adults) 12 |
- |
- |
186 |
3,404 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A07AA01 |
NEOMYCIN SULPHATE |
||||||
P |
2325J |
Tablet 500mg |
5.00 |
GM |
1,062 |
13,747 |
|
A07AA02 |
NYSTATIN |
||||||
P |
1696G |
Tablet 500,000 units |
1500.00 |
TE |
19,975 |
399,729 |
|
P |
1699K |
Capsule 500,000 units |
1500.00 |
TE |
29,924 |
659,557 |
|
A07AA09 |
VANCOMYCIN |
||||||
P |
3113W |
Capsule 125 mg (125,000 i.u.) vancomycin activity |
2.00 |
GM |
858 |
221,228 |
|
P |
3114X |
Capsule 250 mg (250,000 i.u.) vancomycin activity |
2.00 |
GM |
978 |
553,372 |
|
ELECTROLYTES WITH CARBOHYDRATES |
|||||||
ORAL REHYDRATION SALT FORMULATIONS |
|||||||
A07CA |
ELECTROLYTE REPLACEMENT (ORAL) |
||||||
P |
3196F |
Sachets of powder for oral solution 4.87g 10 |
- |
- |
23,754 |
370,773 |
|
ANTIPROPULSIVES |
|||||||
ANTIPROPULSIVES |
|||||||
A07DA01 |
DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE |
||||||
A |
11123 |
Tablet 2.5mg-25ug 100 |
15.00 |
MG |
1,319 |
- |
|
A |
16260 |
Tablet 2.5mg-25ug 8 |
15.00 |
MG |
1,658 |
- |
|
P |
2501P |
Tablet 2.5mg-25ug |
15.00 |
MG |
223,401 |
2,257,444 |
|
A07DA03 |
LOPERAMIDE HYDROCHLORIDE |
||||||
P |
1571Q |
Capsule 2mg |
10.00 |
MG |
255,518 |
4,143,511 |
|
A |
16133 |
Tablet 2mg 8 |
10.00 |
MG |
163 |
- |
|
INTESTINAL ANTIINFLAMMATORY AGENTS |
|||||||
CORTICOSTEROIDS FOR LOCAL USE |
|||||||
A07EA02 |
HYDROCORTISONE ACETATE |
||||||
P |
1502C |
Rectal foam 125mg per applicator (10%) aerosol |
- |
- |
11,434 |
429,097 |
|
A07EA01 |
PREDNISOLONE SODIUM PHOSPHATE |
||||||
P |
1920C |
Retention enema equivalent to 20mg prednisolone |
- |
- |
5,303 |
1,090,194 |
|
P |
2554K |
Suppositories equivalent to 5mg prednisolone 10 |
- |
- |
7,914 |
327,539 |
|
AMINOSALICYLIC ACID AND SIMILAR AGENTS |
|||||||
A07EC04 |
BALSALAZIDE |
||||||
P |
8845M |
Capsule 750mg |
6.75 |
GM |
22,856 |
3,227,643 |
|
A07EC02 |
MESALAZINE |
||||||
P |
1611T |
Tablet 250mg |
1.50 |
GM |
51,054 |
8,102,603 |
|
P |
2214M |
Tablet 500mg (prolonged release) 200 |
1.50 |
GM |
7,413 |
2,146,218 |
|
P |
2234N |
Oral granules (prolonged release) 1g per sachet 100 |
1.50 |
GM |
2,507 |
782,813 |
|
P |
2287J |
Oral granules (prolonged release) 2g per sachet 60 |
1.50 |
GM |
14,454 |
4,555,558 |
|
P |
3413P |
Tablet 1g (prolonged release) 120 |
1.50 |
GM |
6,308 |
2,030,875 |
|
P |
5461K |
Suppository (moulded) 1g 30 |
1.50 |
GM |
645 |
87,922 |
|
P |
8598M |
Oral granules 500mg per sachet 100 |
1.50 |
GM |
2,134 |
552,816 |
|
P |
8599N |
Oral granules 1 mg per sachet 100 |
1.50 |
GM |
18,956 |
5,592,491 |
|
P |
8616L |
Enemas 2g in 60mL 7 |
1.50 |
GM |
2,758 |
918,209 |
|
P |
8617M |
Enemas 4g in 60mL 7 |
1.50 |
GM |
7,826 |
3,493,222 |
|
INTESTINAL ANTIINFLAMMATORY AGENTS |
|||||||
P |
8731M |
Tablet 500mg (enteric coated) |
1.50 |
GM |
56,113 |
16,508,377 |
|
P |
8752P |
Suppository 1g 28 |
1.50 |
GM |
11,087 |
1,443,267 |
|
P |
8753Q |
Enemas 1g in 100mL 7 |
1.50 |
GM |
1,257 |
417,418 |
|
P |
8768L |
Rectal foam 1g per app, 14 apps aerosol 80g 4 |
1.50 |
GM |
1,679 |
553,061 |
|
P |
9206M |
Sachet containing granules 1.5g per sachet |
1.50 |
GM |
8,111 |
2,059,647 |
|
P |
9353G |
Tablet 1.2g (prolonged release) 60 |
1.50 |
GM |
10,559 |
2,723,348 |
|
A07EC03 |
OLSALAZINE SODIUM |
||||||
P |
1728Y |
Capsule 250mg |
1.00 |
GM |
4,553 |
374,744 |
|
P |
8086N |
Capsule 500mg |
1.00 |
GM |
12,875 |
1,651,153 |
|
A07EC01 |
SULPHASALAZINE |
||||||
P |
2093E |
Tablet 500mg |
2.00 |
GM |
25,483 |
1,272,506 |
|
P |
2096H |
Tablet 500mg (enteric coated) |
2.00 |
GM |
192,262 |
10,447,065 |
|
P |
9208P |
Tablet 500mg 200 |
2.00 |
GM |
1,182 |
59,224 |
|
P |
9209Q |
Tablet 500mg (enteric coated) 200 |
2.00 |
GM |
7,373 |
399,311 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A08AA01 |
PHENTERMINE |
||||||
A |
10636 |
Capsule 15mg 30 |
15.00 |
MG |
19,752 |
- |
|
A |
10637 |
Capsule 30mg 30 |
15.00 |
MG |
84,886 |
- |
|
A |
10638 |
Capsule 40mg 30 |
15.00 |
MG |
63,180 |
- |
|
A |
20783 |
Capsule 15mg 30 |
15.00 |
MG |
315 |
- |
|
A |
20784 |
Capsule 30mg 30 |
15.00 |
MG |
45,427 |
- |
|
A |
20785 |
Capsule 40mg 30 |
15.00 |
MG |
35,465 |
- |
|
PERIPHERALLY ACTING ANTIOBESITY PRODUCTS |
|||||||
A08AB01 |
ORLISTAT |
||||||
A |
18494 |
Capsule 120mg 84 |
0.36 |
GM |
1,059 |
- |
|
P |
4570M |
Capsule 120mg 84 |
0.36 |
GM |
2,186 |
306,670 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A09AA02 |
PANCREATIC EXTRACT |
||||||
P |
5453B |
Granules (enteric coated) providing not less than 5000 BP units of lipase activity per 100mg 20g 3 |
- |
- |
1,486 |
205,267 |
|
P |
5454C |
Granules (enteric coated) providing not less than 5000 units of lipase activity per 100mg 20g 3 |
- |
- |
361 |
48,046 |
|
P |
8020D |
Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity |
- |
- |
24,520 |
4,065,209 |
|
P |
8021E |
Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity |
- |
- |
35,922 |
5,742,153 |
|
P |
8556H |
Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity |
- |
- |
727 |
77,875 |
|
P |
9225M |
Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity |
- |
- |
120 |
13,623 |
|
P |
9226N |
Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity |
- |
- |
4,673 |
744,517 |
|
P |
9227P |
Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity |
- |
- |
6,338 |
876,091 |
|
P |
9229R |
Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity |
- |
- |
355 |
52,034 |
|
P |
9412J |
Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200 |
- |
- |
7,499 |
1,747,784 |
|
P |
9413K |
Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200 |
- |
- |
1,410 |
297,844 |
|
A09AA02 |
PANCRELIPASE |
||||||
P |
8366H |
Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity |
- |
- |
2,666 |
376,273 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A10AB02 |
INSULIN (BEEF) |
||||||
P |
1713E |
Injection 100 units per mL 10mL |
40.00 |
IE |
341 |
58,302 |
|
A10AB01 |
INSULIN (HUMAN) |
||||||
P |
1531N |
Injection 100 units per mL 10mL |
40.00 |
IE |
8,279 |
1,064,135 |
|
P |
1762R |
Injection 100 units per mL 3mL 5 |
40.00 |
IE |
19,408 |
4,149,325 |
|
A10AB05 |
INSULIN ASPART |
||||||
P |
8435Y |
Injection (human) 100 units per mL 3mL 5 |
40.00 |
IE |
173,524 |
44,839,686 |
|
P |
8571D |
Injection (human) 100 units per mL 10mL 5 |
40.00 |
IE |
12,572 |
1,982,742 |
|
A10AB06 |
INSULIN GLULISINE |
||||||
P |
1921D |
Injection (human) 100 units per mL 3mL 5 |
40.00 |
IE |
13,168 |
3,440,179 |
|
P |
9224L |
Injection (human) 100 units per mL 10mL 5 |
40.00 |
IE |
226 |
33,547 |
|
A10AB04 |
INSULIN LISPRO |
||||||
P |
8084L |
Injection 100 units per mL 10mL |
40.00 |
IE |
6,744 |
1,073,498 |
|
P |
8212F |
Injection 100 units per mL 3mL 5 |
40.00 |
IE |
35,333 |
9,245,371 |
|
INSULINS AND ANALOGUES INTERMEDIATE-ACTING |
|||||||
A10AC02 |
INSULIN (BEEF) |
||||||
P |
1711C |
Injection 100 units per mL 10mL |
40.00 |
IE |
576 |
98,278 |
|
A10AC01 |
INSULIN (HUMAN) |
||||||
P |
1533Q |
Injection 100 units per mL 10mL |
40.00 |
IE |
13,171 |
1,757,778 |
|
P |
1761Q |
Injection 100 units per mL 3mL 5 |
40.00 |
IE |
38,729 |
8,366,065 |
|
INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING |
|||||||
A10AD01 |
INSULIN (HUMAN) |
||||||
P |
1426C |
Injection 100 units per ml (30 units-70 units) |
40.00 |
IE |
1,767 |
237,644 |
|
P |
1763T |
Injection 100 units per mL (30 units-70 units) |
40.00 |
IE |
76,985 |
17,041,449 |
|
P |
2062M |
Injection 100 units per mL (50 units-50 units) |
40.00 |
IE |
3,644 |
804,588 |
|
A10AD30 |
INSULIN ASPART/PROTAMINE ASPART |
||||||
P |
8609D |
Injection (human analogue) 30/70 units per mL |
40.00 |
IE |
155,105 |
40,439,920 |
|
A10AD04 |
INSULIN LISPRO |
||||||
P |
8390N |
Injection (human analogue) 100 units per mL 3mL 5 |
40.00 |
IE |
18,198 |
4,774,672 |
|
P |
8874C |
Inj (human analogue) 100 units(50/50)per mL 3mL 5 |
40.00 |
IE |
5,516 |
1,448,982 |
|
INSULINS AND ANALOGUES LONG-ACTING |
|||||||
A10AE05 |
INSULIN DETEMIR |
||||||
P |
9040T |
Injection 100 units per mL 3mL 5 |
40.00 |
IE |
35,829 |
15,343,456 |
|
A10AE04 |
INSULIN GLARGINE |
||||||
A |
18353 |
Injection 100 units per mL 10mL |
40.00 |
IE |
547 |
- |
|
P |
9039R |
Injection 100 units per mL 3mL 5 |
40.00 |
IE |
257,833 |
109,484,665 |
|
ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||||
BIGUANIDES |
|||||||
A10BA02 |
METFORMIN HYDROCHLORIDE |
||||||
P |
1801T |
Tablet 850mg |
2.00 |
GM |
301,591 |
3,942,179 |
|
A |
21261 |
Tablet 500mg (extended release) 90 |
2.00 |
GM |
179 |
- |
|
P |
2430X |
Tablet 500mg |
2.00 |
GM |
1,290,364 |
16,460,656 |
|
P |
3439B |
Tablet 1g (extended release) 60 |
2.00 |
GM |
381,603 |
6,308,162 |
|
P |
8607B |
Tablet 1000mg |
2.00 |
GM |
1,215,949 |
21,139,343 |
|
P |
9435N |
Tablet 500mg (extended release) 120 |
2.00 |
GM |
1,335,037 |
21,964,663 |
|
SULFONAMIDES UREA DERIVATIVES |
|||||||
A10BB01 |
GLIBENCLAMIDE |
||||||
P |
2939Q |
Tablet 5mg |
10.00 |
MG |
83,450 |
952,196 |
|
A10BB09 |
GLICLAZIDE |
||||||
P |
2449X |
Tablet 80mg 100 |
60.00 |
MG |
257,742 |
3,390,924 |
|
P |
8535F |
Tablet 30mg (modified release) 100 |
60.00 |
MG |
355,405 |
4,722,109 |
|
P |
9302N |
Tablet 60mg (modified release) 60 |
60.00 |
MG |
1,222,829 |
17,969,372 |
|
A10BB12 |
GLIMEPIRIDE |
||||||
P |
8450R |
Tablet 1mg 30 |
2.00 |
MG |
55,024 |
494,304 |
|
P |
8451T |
Tablet 2mg 30 |
2.00 |
MG |
76,430 |
866,163 |
|
P |
8452W |
Tablet 4mg 30 |
2.00 |
MG |
203,107 |
2,895,328 |
|
P |
8533D |
Tablet 3mg 30 |
2.00 |
MG |
29,316 |
372,847 |
|
A10BB07 |
GLIPIZIDE |
||||||
P |
2440K |
Tablet 5mg 100 |
10.00 |
MG |
55,571 |
659,949 |
|
BIGUANIDES AND SULFONAMIDES IN COMBINATION |
|||||||
A10BD02 |
METFORMIN and SULFONAMIDES |
||||||
P |
8811R |
Tablet 500mg-5mg 90 |
- |
- |
79,548 |
1,346,722 |
|
P |
8838E |
Tablet 250mg-1.25 90 |
- |
- |
2,613 |
34,572 |
|
A10BD02 |
METFORMIN with GLIBENCLAMIDE |
||||||
P |
8810Q |
Tablet 500mg-2.5mg 90 |
- |
- |
37,576 |
583,115 |
|
A10BD08 |
METFORMIN with VILDAGLIPTIN |
||||||
P |
5474D |
Tablet containing 50mg vildagliptin with 500mg metformin hydrochloride 60 |
- |
- |
7,646 |
747,607 |
|
P |
5475E |
Tablet containing 50mg vildagliptin with 850mg metformin hydrochloride 60 |
- |
- |
4,723 |
472,876 |
|
P |
5476F |
Tablet containing 50mg vildagliptin with 1000mg metformin hydrochloride 60 |
- |
- |
28,310 |
2,862,831 |
|
A10BD03 |
ROSIGLITAZONE with METFORMIN |
||||||
P |
9059T |
Tablet 2mg(base)-500mg 56 |
- |
- |
3,864 |
255,969 |
|
P |
9060W |
Tablet 2mg(base)-1000mg 56 |
- |
- |
10,137 |
696,089 |
|
P |
9061X |
Tablet 4mg(base)-500mg 56 |
- |
- |
3,748 |
356,282 |
|
P |
9062Y |
Tablet 4mg(base)-1000mg 56 |
- |
- |
19,508 |
1,915,157 |
|
A10BD07 |
SITAGLIPTIN with METFORMIN |
||||||
P |
9449H |
Tablet 50mg (as phosphate monohydrate) - 500mg 56 |
- |
- |
51,057 |
4,835,444 |
|
P |
9450J |
Tablet 50mg (as phosphate monohydrate) - 850mg 56 |
- |
- |
33,118 |
3,213,666 |
|
P |
9451K |
Tablet 50mg (as phosphate monohydrate) - 1000mg 56 |
- |
- |
190,807 |
18,618,892 |
|
ALPHA GLUCOSIDASE INHIBITORS |
|||||||
A10BF01 |
ACARBOSE |
||||||
P |
8188Y |
Tablet 50mg |
0.30 |
GM |
27,471 |
863,688 |
|
P |
8189B |
Tablet 100mg |
0.30 |
GM |
23,691 |
1,008,487 |
|
THIAZOLIDINEDIONES |
|||||||
A10BG03 |
PIOGLITAZONE HYDROCHLORIDE |
||||||
P |
8694N |
Tablet 15mg (base) 28 |
30.00 |
MG |
83,898 |
4,628,526 |
|
ORAL BLOOD GLUCOSE LOWERING DRUGS |
|||||||
P |
8695P |
Tablet 30mg (base) 28 |
30.00 |
MG |
225,166 |
18,238,325 |
|
P |
8696Q |
Tablet 45mg (base) 28 |
30.00 |
MG |
143,160 |
14,753,594 |
|
A10BG02 |
ROSIGLITAZONE |
||||||
P |
8689H |
Tablet 4mg (base) 28 |
6.00 |
MG |
19,484 |
1,237,488 |
|
P |
8690J |
Tablet 8mg (base) 28 |
6.00 |
MG |
20,513 |
1,885,801 |
|
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS |
|||||||
A10BH03 |
SAXAGLIPTIN |
||||||
P |
8983T |
Tablet 5mg (as hydrochloride) 28 |
5.00 |
MG |
13,430 |
1,225,196 |
|
A10BH01 |
SITAGLIPTIN |
||||||
P |
9180E |
Tablet 25mg (as phosphate monohydrate) 28 |
0.10 |
GM |
23,219 |
2,138,362 |
|
P |
9181F |
Tablet 50mg (as phosphate monohydrate) 28 |
0.10 |
GM |
64,853 |
5,974,761 |
|
P |
9182G |
Tablet 100mg (as phosphate monohydrate) 28 |
0.10 |
GM |
270,711 |
24,720,021 |
|
A10BH02 |
VILDAGLIPTIN |
||||||
P |
3415R |
Tablet 50mg 60 |
0.10 |
GM |
59,648 |
5,795,595 |
|
OTHER BLOOD GLUCOSE LOWERING DRUGS |
|||||||
A10BX04 |
EXENATIDE |
||||||
P |
3423E |
Injection solution 5ug per dose in pre-filled pen 60 doses 1 |
0.02 |
MG |
17,448 |
3,082,452 |
|
P |
3424F |
Injection solution 10ug per dose in pre-filled pen 60 doses 1 |
0.02 |
MG |
39,570 |
6,982,641 |
|
A10BX02 |
REPAGLINIDE |
||||||
A |
16646 |
Tablet 1mg 90 |
6.00 |
MG |
263 |
- |
|
A |
16647 |
Tablet 2mg 90 |
6.00 |
MG |
1,053 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A11CA01 |
VITAMIN A |
||||||
A |
12182 |
Capsule 50 000 units 100 |
50.00 |
TE |
521 |
- |
|
VITAMIN D AND ANALOGUES |
|||||||
A11CC04 |
CALCITRIOL |
||||||
P |
2502Q |
Capsule 0.25ug |
1.00 |
UG |
146,883 |
6,242,866 |
|
A11CC01 |
ERGOCALCIFEROL |
||||||
A |
16060 |
Capsule 25ug 60 |
- |
- |
875,087 |
- |
|
VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12 |
|||||||
THIAMINE (VITAMIN B1) PLAIN |
|||||||
A11DA01 |
THIAMINE HYDROCHLORIDE |
||||||
P |
1070H |
Tablet 100mg |
50.00 |
MG |
34,951 |
388,032 |
|
P |
4043T |
Tablet 100mg |
50.00 |
MG |
26,066 |
289,117 |
|
VITAMIN B-COMPLEX INCL COMBINATIONS |
|||||||
VITAMIN B-COMPLEX PLAIN |
|||||||
A11EA |
VITAMIN B GROUP COMPLEX |
||||||
P |
4493L |
Oral liquid 200mL |
- |
- |
10,226 |
137,042 |
|
OTHER PLAIN VITAMIN PREPARATIONS |
|||||||
OTHER PLAIN VITAMIN PREPARATIONS |
|||||||
A11HA02 |
PYRIDOXINE HYDROCHLORIDE |
||||||
A |
11648 |
Tablet 25mg 100 |
160.00 |
MG |
2,068 |
- |
|
A |
11649 |
Tablet 100mg 50 |
160.00 |
MG |
1,403 |
- |
|
OTHER VITAMIN PRODUCTS COMBINATIONS |
|||||||
VITAMINS WITH MINERALS |
|||||||
A11JB |
VITAMINS with MINERALS |
||||||
A |
12947 |
Capsule 100 |
- |
- |
140 |
- |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A12AA04 |
CALCIUM CARBONATE |
||||||
A |
20271 |
Tablet 600mg (as carbonate) 120 |
3.00 |
GM |
43,767 |
- |
|
P |
3116B |
Tablet (chewable) 500mg (as carbonate) |
3.00 |
GM |
15,098 |
427,794 |
|
P |
3117C |
Tablet 600mg (as carbonate) 240 |
3.00 |
GM |
4,121 |
76,528 |
|
P |
4082W |
Tablet (chewable) 600mg (as carbonate) 120 |
3.00 |
GM |
8,122 |
115,793 |
|
P |
4094L |
Tablet (chewable) 500mg (as carbonate) |
3.00 |
GM |
1,817 |
50,532 |
|
P |
4142B |
Tablet 600mg (as carbonate) 240 |
3.00 |
GM |
1,179 |
24,742 |
|
P |
4333C |
Tablet (chewable) 500mg (as carbonate) 120 |
3.00 |
GM |
5,613 |
102,439 |
|
A12AA |
CALCIUM CITRATE |
||||||
A |
20956 |
Tablet 250mg (as citrate) 120 |
- |
- |
1,313 |
- |
|
CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS |
|||||||
A12AX |
CALCIUM CARBONATE with CHOLECALCIFEROL |
||||||
A |
10600 |
Tablet 600mg 60 |
3.00 |
13,490 |
- |
||
POTASSIUM |
|||||||
POTASSIUM |
|||||||
A12BA01 |
POTASSIUM CHLORIDE |
||||||
P |
2642C |
Tablet 600mg (sustained release) |
3.00 |
GM |
297,926 |
3,751,387 |
|
P |
3012M |
Effervescent tabs 14mmol K,8mmol Cl ions |
3.00 |
GM |
31,396 |
494,148 |
|
OTHER MINERAL SUPPLEMENTS |
|||||||
ZINC |
|||||||
A12CB01 |
ZINC SULPHATE |
||||||
A |
12264 |
Capsule 50mg 100 |
0.60 |
GM |
303 |
- |
|
MAGNESIUM |
|||||||
A12CC05 |
MAGNESIUM ASPARTATE |
||||||
A |
11226 |
Tablet 100 |
- |
- |
2,322 |
- |
|
P |
4321K |
Tablet 37.4mg (as aspartate dihydrate) |
- |
- |
49,265 |
808,311 |
2011 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
ALIMENTARY TRACT AND METABOLISM |
|||||||
A14AB01 |
NANDROLONE DECANOATE |
||||||
P |
1671Y |
Injection 50mg in 1mL disposable syringe |
2.00 |
MG |
4,552 |
102,291 |